Table 3:
Other (non-polyposis) medical comorbidities and sequelae of original anti-cancer treatment (n=34)
| n | %* | |
|---|---|---|
| Non-colorectal neoplasms** | 17 | (50) |
| Barrett’s esophagus | 5 | (15) |
| Non-melanomatous skin cancer | 5 | (15) |
| Breast cancer | 4 | (12) |
| Meningioma | 2 | (6) |
| Prostate cancer | 2 | (6) |
| Schwannoma | 2 | (6) |
| Melanoma | 1 | (3) |
| Non-small cell lung cancer | 1 | (3) |
| Pancreatic adenocarcinoma | 1 | (3) |
| Renal cell carcinoma | 1 | (3) |
| Non-neoplastic conditions | 16 | (47) |
| Cardiovascular | ||
| early onset coronary artery disease | 3 | (9) |
| cardiomyopathy | 2 | (6) |
| heart block | 2 | (6) |
| valvular heart disease | 1 | (3) |
| early cardiac disease (unknown type) | 1 | (3) |
| Endocrine | ||
| hypothyroidism | 7 | (21) |
| hypogonadism | 4 | (12) |
| Gynecologic | ||
| endometriosis/polyps | 2 | (6) |
| uterine fibroids | 2 | (6) |
| Neurologic | ||
| cataracts | 1 | (3) |
| cognitive impairment | 1 | (3) |
| Pulmonary | ||
| pulmonary fibrosis | 2 | (6) |
| Any of the above (neoplastic and/or non-neoplastic) | 25 | (74) |
*
Percentages listed are of total cohort (n=34)
**
Does not include thyroid cancers (n=5) or desmoid tumors (n=2) as these were included in Table 2 as “Extracolonic FAP-related neoplasia”